首页> 外文期刊>Liver international : >Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis
【24h】

Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis

机译:混合谱系激酶3缺陷小鼠可预防高脂高碳水化合物饮食诱发的脂肪性肝炎

获取原文
获取原文并翻译 | 示例
           

摘要

Background & Aims: C-Jun N-terminal kinase (JNK) activation is pivotal in the development of nonalcoholic steatohepatitis (NASH). Mixed lineage kinase 3 (MLK) 3 is one of the mitogen activated protein kinase kinase kinase (MAP3K) that mediates JNK activation in the liver. Despite this concept, the role of MLK3 in modulating liver injury during nutrient excess has not been explored. Our aim was to determine if MLK3 deficient mice were protected against high fat high carbohydrate (HFHC) diet-induced NASH. Methods: We employed eight-week-old Mlk3-/- male C57BL/6J mice, and wild type (WT) mice C57BL/6J as controls. Mice were fed a HFHC or a chow diet adlib for 16 weeks. Results: Hepatic JNK activating phosphorylation was readily absent in the Mlk3-/- mice fed the HFHC diet, but not in WT mice. This inhibition of JNK activation was hepatoprotective. Despite a comparable increase in weight gain, hepatic steatosis by histological examination and hepatic triglyceride quantification was reduced in HFHC diet-fed Mlk3-/- mice compared with WT mice. In addition, compared with the WT mice, HFHC diet-fed Mlk3-/- mice had significantly attenuated liver injury as manifested by reduced ALT levels, hepatocyte apoptosis, markers of hepatic inflammation and indices of hepatic fibrogenesis. Conclusion: Our results suggest that loss of MLK3 in mice is protective against HFHC diet-induced NASH, in a weight-independent fashion, through attenuation of JNK activation. MLK3 is a potential therapeutic target for the treatment of human NASH.
机译:背景与目的:C-Jun N末端激酶(JNK)激活在非酒精性脂肪性肝炎(NASH)的发展中至关重要。混合谱系激酶3(MLK)3是介导肝脏JNK激活的丝裂原活化蛋白激酶激酶(MAP3K)之一。尽管有这个概念,但尚未探索MLK3在营养过剩期间调节肝损伤的作用。我们的目的是确定MLK3缺陷小鼠是否受到高脂高碳水化合物(HFHC)饮食诱导的NASH的保护。方法:我们采用八周大的Mlk3-/-雄性C57BL / 6J小鼠和野生型(WT)小鼠C57BL / 6J作为对照。给小鼠喂HFHC或低脂饮食16周。结果:饲喂HFHC饮食的Mlk3-/-小鼠中肝JNK激活磷酸化很容易,而野生型小鼠则不存在。 JNK激活的这种抑制是肝保护性的。尽管体重增加了相当的增加,但与WT小鼠相比,HFHC饮食喂养的Mlk3-/-小鼠通过组织学检查和肝甘油三酯定量检测得出的肝脂肪变性减少。此外,与WT小鼠相比,HFHC饮食喂养的Mlk3-/-小鼠具有显着减轻的肝损伤,如ALT水平降低,肝细胞凋亡,肝炎标志物和肝纤维化指标所显示。结论:我们的结果表明,小鼠MLK3的丢失可以通过减轻JNK的激活而以体重独立的方式来保护HFHC饮食诱导的NASH。 MLK3是治疗人类NASH的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号